Clinical Trial Update: Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine and cisplatin without cystectomy for muscle-invasive bladder cancer with selected genetic alterations; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING